[6, 34–37] Genetic aberrations activating the JAK-STAT pathway were identified in 28% of T/NK-PTLD, including PTCL, NOS, HSTCL, c-ALCL, and ENKTCL, and an EBV+ PTCL. This evidence concerns the gene SOAT1 and post-transplant lymphoproliferative disease.